Stock MANKIND MANKIND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Market Closed - NSE India S.E.
Other stock markets
 07:43:54 2024-06-27 EDT 		5-day change 1st Jan Change
2,135 INR -0.20% Intraday chart for Mankind Pharma Limited -3.53% +7.70%
06-03 Mankind Pharma Limited Receives Order from Office of Superintendent of Central Tax, Bholakpur, Telangana CI
05-30 Advent International Receives 6-7 Bids for Bharat Serums CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Advent International Receives 6-7 Bids for Bharat Serums
CI
Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4
MT
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment
RE
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Mankind Pharma Reportedly in Fray to Acquire Advent's Stake in Bharat Serums
CI
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy
CI
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis
CI
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary
MT
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products
MT
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited
CI
Mankind Reportedly Joins Race for Healthium Medtech
CI
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India
MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India
CI
India's Jubilant Pharmova posts quarterly profit
RE
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%
MT
India's Mankind Pharma beats Q3 profit estimates on strong demand
RE
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
India's IPO momentum seen growing on prospects of political stability
RE
Mankind Pharma Hikes Stake in UK-Based Biopharma Company
MT
3 PE Firms Reportedly Looking to Sell 5% to 6% Stake in Mankind Pharma via Block Deals
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MANKIND Stock
  4. News Mankind Pharma Limited
  5. Highlights